By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

James van Geelen, founder of Citrini Research, is focused on the next stage of AI, surrounding humanoid robots.

For decades, the theory that has dominated Alzheimer’s research, and drug pipelines, is known as the amyloid hypothesis ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use ...

A new study looked at the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. At the end of the 72 ...

Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...

New York Finding the right tools can make a big difference in your weight loss journey. Check out our curated list of the best weight loss apps to help you stay on track, set goals, and achieve yo ...

About 8 million American teens, or 23% of people ages 12 to 19, have obesity, up from 5% in 1980, according to U.S.

New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for ...

Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...

Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...